國立虎尾科技大學 |

Updates on Clostridium difficile in Europe = Advances in Microbiology, Infectious Diseases and Public Health Volume 8 /

紀錄類型:	書目-語言資料,印刷品 : Monograph/item
正題名/作者:	Updates on Clostridium difficile in Europe/ edited by Paola Mastrantonio, Maja Rupnik.
其他題名:	Advances in Microbiology, Infectious Diseases and Public Health Volume 8 /
其他作者:	Mastrantonio, Paola.
面頁冊數:	VIII, 261 p. 25 illus., 16 illus. in color.online resource. :
Contained By:	Springer Nature eBook
標題:	Medical microbiology. -
電子資源:	https://doi.org/10.1007/978-3-319-72799-8
ISBN:	9783319727998

Updates on Clostridium difficile in Europe = Advances in Microbiology, Infectious Diseases and Public Health Volume 8 /
Updates on Clostridium difficile in EuropeAdvances in Microbiology, Infectious Diseases and Public Health Volume 8 /[electronic resource] :edited by Paola Mastrantonio, Maja Rupnik. - 1st ed. 2018. - VIII, 261 p. 25 illus., 16 illus. in color.online resource. - Advances in Microbiology, Infectious Diseases and Public Health,10502365-2675 ;. - Advances in Microbiology, Infectious Diseases and Public Health,901.

Foreword (P. Mastrantonio and M. Rupnik) -- Economic burden of CDI in European countries (E. Reigadas and E. Bouza) -- The need for European surveillance of CDI(C. Wiuff, A.Lan Banks, F. Fitzpatrick, L. Cottom) -- Diagnostic guidance for C. difficile infections (M.J.T. Crobach,A.Baktash, N. Duszenko, E.J. Kuijper) -- Ribotypes and new virulent strains across Europe (J. Couturier, K. Davies, C. Gateau, F. Barbut) -- Comparative genomics of C. difficile strains (S. Janezic, J.R.Garneau, M. Monot) -- Cellular uptake and mode-of-action of Clostridium difficile toxins (P.Papatheodorou, H. Barth, N. Minton, K. Aktories) -- Clostridium difficile biofilm (C. Vuotto, G. Donelli, A. Buckley, C. Chilton) -- European practice for CDI treatment (F. Fitzpatrick, M. Skally, M. Brady, K. Burns, C. Rooney, M.H. Wilcox) -- Antibiotic resistances of Clostridium difficile (P. Spigaglia, P. Mastrantonio, F. Barbanti) -- Probiotics for prevention and treatment of Clostridium difficile infection (L. Valdés-Varela, M. Gueimonde, P. Ruas-Madiedo) -- Faecal microbiota transplantation as emerging treatment in European countries (M. Maida, J. McIlroy, G. Ianiro, G. Cammarota) -- Immunization strategies against Clostridium difficile (J.F. Bruxelle, S. Péchiné, A. Collignon) -- Non-human C. difficile reservoirs and sources: animals, food, environment (C. Rodriguez Diaz, C. Seyboldt , M. Rupnik) -- The ESCMIDStudy Group for Clostridium difficile: history, role and perspectives (J.E. Coia and E.J. Kuijper).

This book outlines the currently available clinical, epidemiological and experimental data on Clostridium difficile infection (CDI) with special emphasis on studies and results achieved in Europe. The incidence and severity of CDI has increased significantly over the last decade, and the book explains why C. difficile, recently reclassified as Clostridioides difficile, remains a significant challenge, also from economic perspective, to health care systems all over the world. The different reservoirs of this ubiquitous microorganism are reviewed as well as the different factors contributing to its virulence, such as toxins and biofilm formation. The rapid evolution of antibiotic resistance is clearly a concern and in a specific way can influence the CDI epidemiology. Additionally, new emerging strains and comparative genomics studies are discussed for their relevance from epidemiological and evolutionary point of view. The book also gives an overview on diagnostics, therapy and surveillance, all of which are still challenging. Therefore, a closer look is taken on the effect of probiotics as an alternative to antibiotics, for prevention and treatment of CDI. Fecal transplantation from healthy donors, passive immunotherapies and vaccines for patients with recurrences are also discussed in dedicated chapters. The book closes with a summary of the history and the achievements of the European Society of Clinical Microbiology and Infectious Diseases Study Group for Clostridium difficile (ESGCD) written by the current and past presidents of the Society. It is the aim of this book to raise awareness on CDI and to disseminate updated information on its prevention, diagnosis and treatment.

ISBN: 9783319727998

Standard No.: 10.1007/978-3-319-72799-8doiSubjects--Topical Terms:

583124
Medical microbiology.

LC Class. No.: QR46

Dewey Class. No.: 616.9041

Updates on Clostridium difficile in Europe = Advances in Microbiology, Infectious Diseases and Public Health Volume 8 /
LDR:04764nam a22004095i 4500 001 996367
003 DE-He213
005 20200704151346.0
007 cr nn 008mamaa
008 201225s2018 gw | s |||| 0|eng d
020 $a 9783319727998 $9 978-3-319-72799-8
024 7 $a 10.1007/978-3-319-72799-8 $2 doi
035 $a 978-3-319-72799-8
050 4 $a QR46
072 7 $a MMFM $2 bicssc
072 7 $a MED052000 $2 bisacsh
072 7 $a MKFM $2 thema
082 0 4 $a 616.9041 $2 23
245 1 0 $a Updates on Clostridium difficile in Europe $h [electronic resource] : $b Advances in Microbiology, Infectious Diseases and Public Health Volume 8 / $c edited by Paola Mastrantonio, Maja Rupnik.
250 $a 1st ed. 2018.
264 1 $a Cham : $b Springer International Publishing : $b Imprint: Springer, $c 2018.
300 $a VIII, 261 p. 25 illus., 16 illus. in color. $b online resource.
336 $a text $b txt $2 rdacontent
337 $a computer $b c $2 rdamedia
338 $a online resource $b cr $2 rdacarrier
347 $a text file $b PDF $2 rda
490 1 $a Advances in Microbiology, Infectious Diseases and Public Health, $x 2365-2675 ; $v 1050
505 0 $a Foreword (P. Mastrantonio and M. Rupnik) -- Economic burden of CDI in European countries (E. Reigadas and E. Bouza) -- The need for European surveillance of CDI(C. Wiuff, A.Lan Banks, F. Fitzpatrick, L. Cottom) -- Diagnostic guidance for C. difficile infections (M.J.T. Crobach,A.Baktash, N. Duszenko, E.J. Kuijper) -- Ribotypes and new virulent strains across Europe (J. Couturier, K. Davies, C. Gateau, F. Barbut) -- Comparative genomics of C. difficile strains (S. Janezic, J.R.Garneau, M. Monot) -- Cellular uptake and mode-of-action of Clostridium difficile toxins (P.Papatheodorou, H. Barth, N. Minton, K. Aktories) -- Clostridium difficile biofilm (C. Vuotto, G. Donelli, A. Buckley, C. Chilton) -- European practice for CDI treatment (F. Fitzpatrick, M. Skally, M. Brady, K. Burns, C. Rooney, M.H. Wilcox) -- Antibiotic resistances of Clostridium difficile (P. Spigaglia, P. Mastrantonio, F. Barbanti) -- Probiotics for prevention and treatment of Clostridium difficile infection (L. Valdés-Varela, M. Gueimonde, P. Ruas-Madiedo) -- Faecal microbiota transplantation as emerging treatment in European countries (M. Maida, J. McIlroy, G. Ianiro, G. Cammarota) -- Immunization strategies against Clostridium difficile (J.F. Bruxelle, S. Péchiné, A. Collignon) -- Non-human C. difficile reservoirs and sources: animals, food, environment (C. Rodriguez Diaz, C. Seyboldt , M. Rupnik) -- The ESCMIDStudy Group for Clostridium difficile: history, role and perspectives (J.E. Coia and E.J. Kuijper).
520 $a This book outlines the currently available clinical, epidemiological and experimental data on Clostridium difficile infection (CDI) with special emphasis on studies and results achieved in Europe. The incidence and severity of CDI has increased significantly over the last decade, and the book explains why C. difficile, recently reclassified as Clostridioides difficile, remains a significant challenge, also from economic perspective, to health care systems all over the world. The different reservoirs of this ubiquitous microorganism are reviewed as well as the different factors contributing to its virulence, such as toxins and biofilm formation. The rapid evolution of antibiotic resistance is clearly a concern and in a specific way can influence the CDI epidemiology. Additionally, new emerging strains and comparative genomics studies are discussed for their relevance from epidemiological and evolutionary point of view. The book also gives an overview on diagnostics, therapy and surveillance, all of which are still challenging. Therefore, a closer look is taken on the effect of probiotics as an alternative to antibiotics, for prevention and treatment of CDI. Fecal transplantation from healthy donors, passive immunotherapies and vaccines for patients with recurrences are also discussed in dedicated chapters. The book closes with a summary of the history and the achievements of the European Society of Clinical Microbiology and Infectious Diseases Study Group for Clostridium difficile (ESGCD) written by the current and past presidents of the Society. It is the aim of this book to raise awareness on CDI and to disseminate updated information on its prevention, diagnosis and treatment.
650 0 $a Medical microbiology. $3 583124
650 0 $a Infectious diseases. $3 1102043
650 0 $a Microbiology. $3 591510
650 1 4 $a Medical Microbiology. $3 668401
650 2 4 $a Infectious Diseases. $3 668393
700 1 $a Mastrantonio, Paola. $e editor. $4 edt $4 http://id.loc.gov/vocabulary/relators/edt $3 1287525
700 1 $a Rupnik, Maja. $e editor. $4 edt $4 http://id.loc.gov/vocabulary/relators/edt $3 1287526
710 2 $a SpringerLink (Online service) $3 593884
773 0 $t Springer Nature eBook
776 0 8 $i Printed edition: $z 9783319727981
776 0 8 $i Printed edition: $z 9783319728001
776 0 8 $i Printed edition: $z 9783319892108
830 0 $a Advances in Microbiology, Infectious Diseases and Public Health, $x 2365-2675 ; $v 901 $3 1268224
856 4 0 $u https://doi.org/10.1007/978-3-319-72799-8
912 $a ZDB-2-SBL
912 $a ZDB-2-SXB
950 $a Biomedical and Life Sciences (SpringerNature-11642)
950 $a Biomedical and Life Sciences (R0) (SpringerNature-43708)